Outshine Properties

Private Investment Firm New York, United States ·Founded 2020

Overview

Outshine Properties is a real estate investment and development firm specializing in knowledge economy assets. Founded in 2020, the company invests strategically across life science, medical office, and technology-focused assets nationally, with an emphasis on major life science markets. The firm's principal has acquired and managed over 20 properties valued at more than $4 billion and encompassing 7 million square feet in the past 15 years. Outshine's investment strategy focuses on 'secondary locations within primary markets' and 'primary locations within secondary markets,' capitalizing on supply constraints in the life sciences industry. This approach involves off-market sourcing and accretive asset repositioning, including strategic conversions from office to lab facilities. The firm targets markets with high intellectual capital, particularly those with research-driven institutions facing inadequate facilities. Outshine's investment parameters include life science, medical office, and knowledge-economy-based assets serving the pharmaceutical, biotechnology, medical device, and medical fields. The firm invests in both urban/suburban and university markets for research, development, and biomanufacturing aspects of the vertical, employing core+, value-add, and opportunistic investing strategies. Notable acquisitions include 14 Wall Street in New York, NY; 1951 NW 7th Ave in Miami, FL; Center of Excellence in Bridgewater, NJ; 14200 Shady Grove in Rockville, MD; 156 William Street in New York, NY; 825 Washington Street in Norwood, MA; Pacific Research Center in Newark, CA; 907 Market Street in Philadelphia, PA; 95 Greene in Jersey City, NJ; 3 Blackfan Circle in Boston, MA; 130 Shoreline Drive in Boston, MA; and 7 Powderhorn in Warren, NJ. These acquisitions reflect Outshine's commitment to enhancing the life sciences sector through strategic investments and developments.

Investment Focus

  • Focus on life science, medical office, and technology-focused assets
  • Emphasis on major life science markets
  • Interest in both urban/suburban and university markets
  • Preference for core+, value-add, and opportunistic investment strategies

Portfolio Companies

14 Wall Street1951 NW 7th AveCenter of Excellence14200 Shady Grove156 William Street825 Washington StreetPacific Research Center907 Market Street95 Greene3 Blackfan Circle130 Shoreline Drive7 Powderhorn

Reach Outshine Properties directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Outshine Properties

What sectors does Outshine Properties invest in?

Outshine Properties invests in Technology, Life Sciences and Medical Office, and is based in New York, United States. Outshine Properties is listed as a private investment firm in the ConnectSafely investor database.

What stage does Outshine Properties invest at?

Outshine Properties backs companies at Growth and Late Stage.

Which regions does Outshine Properties invest in?

Outshine Properties invests across United States.

Who are the partners at Outshine Properties?

Team members listed for Outshine Properties include Jonathan Scheinberg (Founder and Managing Principal).

What companies has Outshine Properties invested in?

Outshine Properties's portfolio includes 14 Wall Street, 1951 NW 7th Ave, Center of Excellence, 14200 Shady Grove, 156 William Street, 825 Washington Street, Pacific Research Center and 907 Market Street.

How do I contact Outshine Properties?

Outshine Properties's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database